The Lung Part 10 Flashcards
Small cell carcinoma
- highly malignant tumor with strong relationship to cigarette smoking!!
- can arise in major bronchi or in periphery of lung
- no known pre-invasive phase
- MOST AGGRESSIVE of lung tumors, metastasizing widely; always fatal!
Small cell carcinoma is comprised of (morphology)
- relatively small cells with scant cytoplasm, ill-defined cell borders, finely granular nuclear chromatin (salt and pepper pattern) and absent or inconspicuous nucleoli
- cells are round, oval, spindle shaped and nuclear molding is prominent
- high mitotic count
How do small cell carcinoma cells grow (pattern)? What is common in SCC?
- grow in clusters that exhibit neither glandular nor squamous organization
- Necrosis is common and often extensive
Azzopardi effect
-in SCC, the presence of basophilic staining of vascular walls due to encrustation by DNA from necrotic tumor cells
Grading of small cell carcinomas
-All are high grade!
Combined small cell carcinoma
-variant in which typical small cell carcinoma is mixed with non small cell histologies like large cell neuroendocrine carcinoma and even spindled cell morphologies resembling sarcoma
EM of small cell carcinoma
-dense core neurosecretory granules in 2/3 of cases
small cell carcinoma originates from what kind of cells? How do we know this?
- originates from neuroendocrine progenitor cells which are present in the lining bronchial epithelium
- know this bc of:
- -occurrence of neurosecretory granules
- -expression of neuroendocrine markers like chromogranin, synaptophysin and CD57
- -ability of tumor to secrete hormones (parathormone-related protein, cause of paraneoplastic hypercalcemia)
Of the lung cancers, which one is most commonly associated with ectopic hormone production?
-Small cell carcinoma
Immunohistochemistry demonstrates high levels of ____ protein _____ in 90% of SCC tumors
-anti-apoptotic protein BCL2
Large cell carcinoma
- undifferentiated malignant epithelial tumor that lacks cytologic features of other forms of lung cancer
- large nuclei, prominent nucleoli, moderate cytoplasm
- Dx of exclusion since doesn’t express any of the markers associated with adenocarcinomas (TTF-1, napsin A) or squamous cell carcinomas
Large neuroendocrine carcinoma
- variant of LCC
- molecular features similar to SCC but cells are larger
Any type of lung carcinoma may extend on to the
- pleural surface and then within the pleural cavity or into the pericardium
- Metastases to the bronchial, tracheal, and mediastinal nodes can be found in most cases
- 50% nodal involvement
Distant spread of lung carcinomas occurs through
- both lymphatic and hematogenous pathways
- often spread early throughout body EXCEPT squamous cell carcinoma which metastasizes outside the thorax LATE
- No organ spared, but almost always involves ADRENALS
- Liver, brain and bone are additional favored sites
Combined carcinoma
-10% of all lung cancers have combined histology of the other types of carcinomas (adeno, squamous, small cell etc)
Secondary pathology associated with lung cancer
- Local effects distal to bronchial involement
- Partial obstruction–> FOCAL EMPHYSEMA
- Total obstruction–>atelectasis
- impaired airway drainage–>severe suppurative or ulcerative bronchitis or bronchiectasis
- Pulmonary abscesses
- SVC Compression/invasion–>venous congestion/edema leading to circulatory compromise (SVC SYNDROME)
- Extension to pericardial or pleural sacs may cause pericarditis or pleuritis with significant effusions
Clinical course of lung cancer
- slow and aggressive
- found in patients in their 50s or older whose symptoms are of several months duration
- CC: cough, weight loss, chest pain, dyspnea
- Commonly discovered by secondary spread of primary or neoplastic neoplasm elsewhere
Symptoms of metastases in lung cancer
- depends on site
- back pain in bone metastasis
- Headache, hemiparesis, CN damage and seizures in brain metastasis
Lung cancer prognosis
-Poor prognosis–5 yr survival=16%
-early detection trial produced 20% reduction in lung cancer related mortality by screening high risk pts.
-
prognosis of adenocarcinoma and squamous cell carcinoma vs undifferentiated cancers
-Adenocarcinomas and squamous cell carcinomas remain localized longer so have slightly better prognosis than undifferentiated cancers which are usually advanced by the time they are discovered
How to prolong survival in adenocarcinoma of the lung
- Target treatment against activating mutations in EGFR or other tyrosine kinase with specific inhibitors of mutated kinases
- many tumors that recur carry new mutations resistant to such inhibitors–evidence that the drugs are hitting target